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S U M M A R Y
Background: An accelerated evolution of HIV to AIDS has been reported with brucellosis co-infection. The
seroprevalence of brucellosis co-infection with HIV has not been investigated in a brucellosis endemic
country like Iran.
Methods: We performed a cross-sectional survey of brucellosis serology in HIV-infected patients
attending a university hospital, as well as in healthy controls. A total of 90 HIV-positive patients and 100
healthy age-matched controls were recruited. The clinical characteristics, hemoglobin, and red blood
cell, platelet, white blood cell, and CD4+ T cell counts were evaluated.
Results: Positive brucellosis serology was signiﬁcantly higher in HIV-infected patients than in controls
(73.3% vs. 30%, respectively, odds ratio 6.42, p < 0.001). It was also higher in males than females,
p = 0.001. Brucellosis-infected patients had signiﬁcantly lower hemoglobin and white blood cell counts
compared with brucellosis-uninfected patients (p < 0.001). In HIV-positive patients, white blood cell
count was signiﬁcantly lower in brucellosis-infected than brucellosis-uninfected patients (p < 0.05).
Conclusions: Our ﬁndings show that brucellosis infection is an important infection in HIV-infected
patients. The treatment of brucellosis may be of great clinical importance in the management of HIV
infection in a brucellosis endemic country like Iran.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Brucellosis is a zoonotic disease with a low level of surveillance
and reporting in endemic areas, like Iran.1–3 Brucella species are
small Gram-negative non-motile intracellular coccobacilli that can
infect many wild and domestic animals, as well as humans.4 It can
infect all human tissues with various clinical manifestations.5–8
Nonetheless, the majority of infected patients in endemic areas are
asymptomatic and fewer than 10% of human cases with brucellosis
may be recognized early after infection.9,10
Infection with the human immunodeﬁciency virus (HIV) is
associatedwith a profound humoral and cellular immune response
defect,11,12 and a great susceptibility to opportunistic infections.
Bacterial infections are the most common opportunistic infections
in these patients.13 The eradication of brucellosis is largely
dependent on both cell-mediated and humoral immunity.14,15
Therefore, HIV-infected patients are theoretically prone to
brucellosis infection. This is of greater importance in areas
endemic for brucellosis. Nonetheless, to the best of our knowledge,
the seroprevalence of brucellosis co-infection with HIV has not
been investigated in brucellosis endemic areas.* Corresponding author. Tel.: +98 912 1220588; fax: +98 21 88277321.
E-mail address: dr_p_abdollahi@yahoo.com (A. Abdollahi).
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doi:10.1016/j.ijid.2010.04.007More aggressive forms of brucellosis have been reported in
immune-compromised patients.16,17 Therefore, in HIV patients,
brucellosis should be diagnosed before the evolution of aggressive
forms. Brucellosis infection should always be considered in the
differential diagnosis of suspicious symptoms like high fever,
neutropenia, lower back pain, and acute abdominal pain in
immune-compromised hosts living in endemic areas, as prompt
antimicrobial therapy is of great clinical importance in these
patients.17 However, routine serological surveillance of brucellosis
is not practiced in almost all of the endemic countries.1
Iran has a high prevalence of Brucella infection,18,19 and a
signiﬁcant lack of access to care among HIV-infected patients due
to the limited drug availability, cost of treatment, and non-
compliance.20 Hence it is of great clinical importance to have an
estimation of brucellosis–HIV co-infection in a country like Iran.
The aim of this study was to compare brucellosis serology in HIV-
infected patients and healthy subjects.
2. Methods
We performed a cross-sectional survey of brucellosis serology
in HIV-infected patients attending the high-risk behavior clinic of a
university hospital, as well as in healthy controls. HIV was
diagnosed using an enzyme-linked immunosorbent assay (ELISA)




HIV-negative (n=100) HIV-positive (n=90)
Age (years) 34.80.71 36.51.03 NS
Males, n (%) 55 (55%) 68 (75.6%) 0.003
Brucellosis infection, n (%)
Positive serology 30 (30%) 66 (73.3%) 0.003
Negative serology 70 (70%) 24 (26.7%)
CD4 count (cells/ml) - 297.6514.68
Hemoglobin (mg/dl) 14.35 0.11 11.930.12 <0.001
Red blood cell count ( 1012/l) 4.630.06 4.14 0.09 <0.001
White blood cell count ( 109/l) 6.830.21 4.61 0.16 <0.001
Platelet count (109/l) 266.4306.89 253.0007.44 NS
Variables are expressed as mean standard error, unless otherwise stated.
NS, not signiﬁcant.
[(Figure_1)TD$FIG]
Figure 1.White blood cell count ( 109/l) according to brucellosis serology in HIV-
infected patients.
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therapy (HAART). A total of 90 HIV-positive patients and 100
healthy age-matched controls were recruited. Demographic data
including age and sex, and hemoglobin and cell counts (red blood
cell (RBC), white blood cell (WBC), and platelets) were investigated
for all participants. The CD4+ T cell count was measured in HIV-
infected patients.
This research was carried out according to the principles of the
Declaration of Helsinki. The local ethics review committee of
Tehran University of Medical Sciences approved the study
protocol. All participants gave written informed consent before
participation.
2.1. Blood samples
Infection with HIV was diagnosed in all cases by an enzyme
immunoassay, and conﬁrmed with Western blot. The diagnosis of
brucellosis was demonstrated by high or rising titers of antibodies
to Brucella smooth lipopolysaccharide in the serum. Standard
procedures includingWright, 2ME, and Coombs–Wrightwere used
for serological testing. Positive results were conﬁrmed by ELISA
method (IBL, Germany). CD4+ T lymphocyte measurements were
carried out using single platform ﬂow cytometry (Partec-Pas,
Germany).
2.2. Statistical analysis
Variables distributed normally are presented as the mean and
standard error of the mean (SEM). To compare the prevalence of
brucellosis infection betweenmales and females, and also between
HIV-positive and HIV-negative patients, Chi-square analysis was
employed. The independent samples t-test was used to compare
RBC and WBC counts, hemoglobin, and platelet counts in the HIV-
positive andHIV-negative groups. The statistical package SPSS v.17
forWindows (SPSS Inc., Chicago, IL, USA), was used for the analysis.
Signiﬁcance was set at a p-value lower than 0.05.
3. Results
Patient characteristics are presented in Table 1. There was no
signiﬁcant difference between HIV-positive and HIV-negative
patients with respect to age and platelet count. Hemoglobin and
RBC andWBC counts were signiﬁcantly lower in HIV-infected than
HIV-uninfected patients (p < 0.001). Positive brucellosis serology
was signiﬁcantly higher in HIV-infected patients than in healthy
controls (odds ratio 6.42, p < 0.001); it was also higher in males
than in females (57% vs. 34%, p = 0.005).
Brucellosis-infected patients compared with brucellosis-unin-
fected patients had signiﬁcantly lower hemoglobin (12.29  0.19vs. 13.61  0.17, respectively; p < 0.001) and WBC counts
(5.03  0.21 vs. 6.56  0.22, respectively; p < 0.001). In HIV-positive
patients, WBC count was signiﬁcantly lower in brucellosis-infected
than brucellosis-uninfected patients (4.58  0.19 vs. 5.45  0.45,
respectively; p < 0.05) (Figure 1). No signiﬁcant difference was found
in RBC count, platelet count, CD4 count, and hemoglobin in HIV-
positive patients with (n = 66) and without (n = 24) brucellosis
infection.
4. Discussion
Brucellosis is transmitted to humans mainly by direct contact
with infected animals or the ingestion of unpasteurized milk or
dairy products. Abattoir workers, veterans , and technicians are at
increased risk of disease transmission through contaminated
aerosols. Blood transfusion is a possible but very unusual route of
infection.5,6,21 So risk factors for HIV infection do not play a
signiﬁcant role in brucellosis infection.
In Iran, HIV-infected patients are usually from groups of lower
socioeconomic status, as well as veterans and abattoir workers.
This may explain the higher rate of brucellosis infection in these
patients. The other explanation is that HIV infection is capable of
inducing a state of profound immune dysregulation,which results
in B cell hyperactivation and hypergammaglobulinemia.22–24
Hyperglobulinemia caused by HIV infection may result in
systematic false-positive tests for Brucella by enzyme immuno-
assay.
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brucellosis infection in HIV patients comes from the defective cell-
mediated and humoral immunity in HIV patients. HIV infection is
associated with impaired production of antibodies against speciﬁc
antigens and a loss of B cell memory.23 Reduced levels ofmemory B
lymphocytes in HIV-infected patients correlate with defective
humoral immunity and a source of abnormal IgG production in
these patients.24 This immune failure results in a higher rate of
bacterial infection, such as brucellosis. Studies, supporting this
description have shown more aggressive forms of brucellosis in
immune-compromised and HIV-infected patients.17,25
Our results, which show a signiﬁcantly higher prevalence of
brucellosis-positive serology in HIV-infected patients, have not
been reported previously. In a survey of 12 HIV-infected patients
from 23 hospitals in Spain, a very low incidence of brucellosis
infectionwith a low rate of relapse was reported.26We did not ﬁnd
any other studies investigating brucellosis infection among HIV
patients.
We also found a higher incidence of brucellosis infection in
males than in females, which has also been found in other
studies.10 This may be due to the confounding effect of occupation,
as males are more exposed to animal products in Iran compared to
females.
Hematological abnormalities are considered a common com-
plication in HIV-infected patients;27 anemia is the most common
hematological abnormality in these patients.27,28 Brucellosis
infection is also associated with bone marrow suppression.29,30
In this study, we found a signiﬁcant difference in hemoglobin and
RBC count between HIV-infected patients and controls. Serum
hemoglobin was also signiﬁcantly lower in brucellosis-infected
than in brucellosis-uninfected patients. We did not ﬁnd any
signiﬁcant difference in serum hemoglobin and RBC count in HIV-
infected patients stratiﬁed according to brucellosis serology.
Leukopenia is a prevalent manifestation of HIV infection and
one of the most important clinical manifestations of brucello-
sis.30,31 It has been shown that brucellosis relapse ismore common
in those with lymphopenia and immune suppression.16,18,32 These
ﬁndings are in linewith our results, asWBCwas signiﬁcantly lower
in both HIV-positive and brucellosis-infected patients compared
with their uninfected counterparts. Additionally, our results show
a lower level of WBC count in HIV patients infected with
brucellosis compared with HIV patients not infected with
brucellosis.
In conclusion, we have shown that brucellosis infection has a
higher prevalence among HIV-infected patients. This may help in
the management of HIV infection in brucellosis endemic regions,
like Iran. The principle limitation of the present study is its cross-
sectional nature which precludes the determination of causality;
however, we took advantage of a relatively large sample size plus
control group.
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